Element Pointe Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Element Pointe Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-60,310	Closed	-$3.69M	–	88
2021 Q4	$3.69M	Sell	60,310 -20,175	-25%	-$1.39M	1.14%	15
2021 Q3	$6.01M	Sell	80,485 -1,068	-1%	-$89.6K	2.03%	10
2021 Q2	$7.1M	Buy	81,553 +4,228	+5%	+$359K	2.15%	9
2021 Q1	$6.86M	Buy	77,325 +17,607	+29%	+$1.75M	2.3%	8
2020 Q4	$5.57M	Buy	59,718 +38,349	+179%	+$3.06M	2.07%	10
2020 Q3	$1.36M	Buy	21,369 +16,025	+300%	+$939K	0.61%	25
2020 Q2	$278K	Buy	+5,344	New	+$229K	0.14%	78

Other funds holding ARKG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Element Pointe Advisors's ARKG Position: Q1 2022 in Review

Element Pointe Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 60,310 shares — an estimated $3.69M sold.

Element Pointe Advisors first reported a position in ARKG in Q2 2020 and held it in 7 quarters. The position peaked at $7.1M in Q2 2021. 388 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

Element Pointe Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
Element Pointe Advisors sold 60,310 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $3.69M.
Element Pointe Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 7 quarters.
Element Pointe Advisors's ARK Genomic Revolution ETF position peaked at $7.1M in Q2 2021.
388 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Element Pointe Advisors's 13F filing for Q1 2022, filed 11 May 2022.